Adjunctive homeopathic treatment of hospitalized COVID-19 patients (COVIHOM): A retrospective case series. (August 2021)
- Record Type:
- Journal Article
- Title:
- Adjunctive homeopathic treatment of hospitalized COVID-19 patients (COVIHOM): A retrospective case series. (August 2021)
- Main Title:
- Adjunctive homeopathic treatment of hospitalized COVID-19 patients (COVIHOM): A retrospective case series
- Authors:
- Takacs, Michael
Frass, Michael
Walder, Gernot
Fibert, Philippa
Rottensteiner, Maria
Glück, Walter
Lechleitner, Peter
Oberbaum, Menachem
Leisser, Ilse
Chandak, Kavita
Panhofer, Peter
Weiermayer, Petra - Abstract:
- Abstract: Background: and purpose. COVID-19 is a novel viral disease causing worldwide pandemia. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to hospitalized patients with confirmed symptomatic SARS-CoV-2 infection. Patient presentation: Thirteen patients with COVID-19 were admitted. Mean age was 73.4 ± 15.0 (SD) years. Twelve (92.3%) were speedily discharged without relevant sequelae after 14.4 ± 8.9 days. A single patient admitted in an advanced stage of septic disease died in hospital. A time-dependent improvement of relevant clinical symptoms was observed in the 12 surviving patients. Six (46.2%) were critically ill and treated in the intensive care unit (ICU). Mean stay at the ICU of the 5 surviving patients was 18.8 ± 6.8 days. In six patients (46.2%) gastrointestinal disorders accompanied COVID-19. Conclusion: The observations suggest that adjunctive homeopathic treatment may be helpful to treat patients with confirmed COVID-19 even in high – risk patients especially since there is no conventional treatment of COVID-19 available at present. Highlights: A time-dependent improvement in 12 out of 13 hospitalized COVID-19 patients was observed with adjunctive homeopathy. Homeopathy appeared to be helpful even in critically ill COVID-19 patients needing intensive care treatment. Homeopathic medicinal products were well tolerated with no side effects observed even in high-risk COVID-19 patients. Products wereAbstract: Background: and purpose. COVID-19 is a novel viral disease causing worldwide pandemia. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to hospitalized patients with confirmed symptomatic SARS-CoV-2 infection. Patient presentation: Thirteen patients with COVID-19 were admitted. Mean age was 73.4 ± 15.0 (SD) years. Twelve (92.3%) were speedily discharged without relevant sequelae after 14.4 ± 8.9 days. A single patient admitted in an advanced stage of septic disease died in hospital. A time-dependent improvement of relevant clinical symptoms was observed in the 12 surviving patients. Six (46.2%) were critically ill and treated in the intensive care unit (ICU). Mean stay at the ICU of the 5 surviving patients was 18.8 ± 6.8 days. In six patients (46.2%) gastrointestinal disorders accompanied COVID-19. Conclusion: The observations suggest that adjunctive homeopathic treatment may be helpful to treat patients with confirmed COVID-19 even in high – risk patients especially since there is no conventional treatment of COVID-19 available at present. Highlights: A time-dependent improvement in 12 out of 13 hospitalized COVID-19 patients was observed with adjunctive homeopathy. Homeopathy appeared to be helpful even in critically ill COVID-19 patients needing intensive care treatment. Homeopathic medicinal products were well tolerated with no side effects observed even in high-risk COVID-19 patients. Products were satisfactorily applied by untrained clinicians using a bespoke algorithm. … (more)
- Is Part Of:
- Complementary therapies in clinical practice. Volume 44(2021)
- Journal:
- Complementary therapies in clinical practice
- Issue:
- Volume 44(2021)
- Issue Display:
- Volume 44, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 44
- Issue:
- 2021
- Issue Sort Value:
- 2021-0044-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-08
- Subjects:
- Complementary therapies -- COVID-19 -- Homeopathy -- Intensive care unit -- SARS-CoV-2
Integrative medicine -- Periodicals
Integrative medicine -- Research -- Periodicals
Alternative medicine -- Periodicals
615.5 - Journal URLs:
- http://www.sciencedirect.com/science/journal/17443881 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ctcp.2021.101415 ↗
- Languages:
- English
- ISSNs:
- 1744-3881
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3364.203747
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 18589.xml